Bank Maspion Indonesia PT (BMAS)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 380.00 |
|---|---|
| 52-week range | 380.00 – 725.00 |
| Return, 1 month / 3 months | −24.8% / −24.0% |
| Return, 1 year / 3 years | −42.9% / −49.0% |
| Trend | Below its 200-day average |
| RSI (14) | 20 |
| Volatility (1 year) | 41.2% |
| Worst drawdown (1 year) | -46.9% |
| Average daily value traded | 188.46M IDR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bank Maspion Indonesia is an Indonesian commercial bank based in Surabaya. It provides retail and commercial banking services, including savings and deposit accounts, lending, and payment services, to individual customers and small and medium-sized businesses. The bank is associated with the Maspion Group, an Indonesian manufacturing conglomerate, and serves customers mainly in East Java and other parts of Indonesia through its branch network.
The shares are listed on the Jakarta Exchange in Indonesia under the code BMAS, and the price on this page is in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bank Maspion Indonesia PT (BMAS) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 380.00 on 19 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 517 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 42.9% and over the last three months it fell 24.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -25.5% | ||
| From 52-week high | -46.9% | ||
| Momentum | 33 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.0% | ||
| 6-month return | -24.0% | ||
| 12-month return, skipping the last month | -24.1% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.9% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 188.46M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −21.5% |
|---|---|
| 1 month | −24.8% |
| 3 months | −24.0% |
| 6 months | −24.0% |
| 1 year | −42.9% |
| 3 years | −49.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 496.66 / 510.38 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 23.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Sep 2021 | IDR 2.8868 |
| 8 Jul 2019 | IDR 3.0793 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.